Division of Hematology and Oncology
Monday – Friday
8:30 am – 5:00 pm
Contact our appointment line at 202-444-2223 for the availability of your specific doctor and the type of service you require.
Currently Available Clinical Trials from Georgetown Lombardi
You will be redirected to our clinical partner, MedStar Georgetown University Hospital.
About the Cancer
Georgetown Lombardi is committed to providing you with the most current information and resources available on Leukemias, including but not limitied to: Chronic Lymphocytic, Chronic Myelogenous, Acute Lymphoblastic, Acute Myeloid, Hairy Cell Leukemia, and Myelodysplastic/Myeloproliferative Diseases. And on Lymphoma Cancers (including, but not limited to: leukemia, multiple myeloma, Hodgkin’s Disease and non-Hodgkin’s).
Current information about all Leukemias, incidence and survival statistics, treatment options, causes and prevention, coping strategies, clinical trials, and research, are available online from the National Cancer Institute at the National Institutes of Health.
Current information about Lymphoma Cancers, incidence and survival statistics, treatment options, causes and prevention, coping strategies, clinical trials, and research, are available online from the National Cancer Institute at the National Institutes of Health.
What We Offer
Our team uses state-of-the-art treatments and comprehensive supportive services to provide you the best care possible.
- Patient and Family Resources
- Clinical Trials. Through the MedStar Health network, MedStar Lombardi/Georgetown University Hospital, we are pleased to offer you access to our cutting-edge clinical trials. Search clinical trials | Learn more about clinical trials.
Georgetown Lombardi’s world-renowned Research Faculty are discovering cancer risk factors, designing effective prevention strategies, and learning how to detect cancers earlier. They are developing and testing the cancer treatments of tomorrow – targeted therapies that will improve both survival and quality of life. They are making progress toward the ultimate goal: to eradicate cancer.